We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify
Industry Insight

Technology Networks recently spoke with Joe Foster, COO, Mogrify, to learn about the biotech company's proprietary platform, the challenges encountered in developing cell therapies and to gain Mogrify's insights on the future of this exciting research space.

Read More

Looking to the Future of Cell and Gene Therapies
Industry Insight

Technology Networks recently spoke with three of the leaders in the cell and gene therapy space, Allogene Therapeutics, bluebird Bio and Mogrify to gain their insights on the next developments in this space.

Read More

Companion Diagnostic Will Support NSCLC Clinical Trials
Industry Insight

To learn more about some of the ways that companion diagnostics can benefit oncology patients, Technology Networks spoke to Dr Luca Quagliata, Global Director of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific.

Read More

Further Analysis of SARS-CoV-2 Genome Suggests It Is Stable
Industry Insight

Two teams of scientists in Italy have collaborated on a project that further analyzed the SARS-CoV-2 genome from locally acquired samples. Technology Networks spoke with Professor Stefano Menzo, virologist, and Dr. Valerio Onofri, geneticist, affiliates of the Department of Excellence of Biomedical Science and Public Health, Marche Polytechnic University in Ancona, to learn more about the findings.

Read More

Using Fast-growing Tobacco Plants To Develop a COVID-19 Vaccine
Industry Insight

Technology Networks recently spoke to David O’Reilly, PhD, Director of Scientific Research at BAT to learn more about the tobacco plant “biomanufacturing factories” that are being used to develop a COVID-19 vaccine. We also discuss the challenges faced when developing a vaccine and the benefits tobacco plants offer compared to conventional vaccine development methods.

Read More

Developing Personalized Strategies To Maximize Cancer Therapy Success
Industry Insight

Technology Networks recently spoke with Ofer Sharon, CEO of OncoHost, to learn more about ways to overcome patient resistance to immunotherapy and how proteomic profiling in oncology can aid diagnosis, prognosis and treatment of this incredibly complex disease.

Read More

Developing Antibodies and Antigens for COVID-19 Diagnostics
Industry Insight

Technology Networks recently spoke to Dr Andy Lane, Commercial Director, The Native Antigen Company, to learn how SARS-CoV-2 antigens and antibodies can be used to drive the development of COVID-19 diagnostics.

Read More

Scaling Up Primer and Probe Kits for COVID-19 Testing
Industry Insight

Technology Networks spoke to Trey Martin, President, IDT, to find out exactly how primers and probes work, and learn about the important role they can play in COVID-19 testing.

Read More

Less Time Managing Inventory, More Time at the Bench? Yes Please
Industry Insight

Lab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.

Read More

Advancing ALS Research With Omics Analysis Technology
Industry Insight

Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.

Read More

 
Advertisement